← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	76 IN8bio INAB $11.7M	22	+3	+16%	$7.45M
77	77 Lunai Bioworks LNAI $3.74M	22	+2	+10%	$982K
78	78 BioCardia BCDA $14.2M	20	+2	+11%	$812K
79	79 Imunon IMNN $5.95M	20	+3	+18%	$1.76M
80	80 Estrella Immunopharma ESLA $23.3M	15	+2	+15%	$1.56M
81	81 Genenta Science GNTA $32.3M	15	+9	+150%	$4.04M
82	82 Pluri PLUR $11.9M	15	-4	-21%	$78.2K
83	83 Senti Biosciences Holdings SNTI $8.14M	15	-1	-6%	$5.84M
84	84 Creative Medical Technology CELZ $6.21M	14	+2	+17%	$253K
85	85 BioRestorative Therapies BRTX $2.02M	12	0	0%	$383K
86	86 Eterna Therapeutics ERNA $2.53M	11	0	0%	$627K
87	ADAP 87 DELISTED Adaptimmune Therapeutics ADAP	10	-45	-82%	$79.7K
88	88 Genprex GNPX $1.88M	9	-4	-31%	$13K
89	89 DELISTED Carisma Therapeutics CARM	7	-26	-79%	$67K
90	90 CytoMed Therapeutics GDTC $10.4M	5	+3	+150%	$70.8K
91	ACHL 91 DELISTED Achilles Therapeutics ACHL	2	0	0%	$7.82K
92	PTE 92 DELISTED PolarityTE, Inc. Common Stock PTE	2	0	0%	–
93	ATHX 93 DELISTED Athersys, Inc. Common Stock ATHX	1	0	0%	–
94	94 DELISTED CATALENT, INC. CTLT	1	0	0%	$63
95	KRBP 95 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	1	+1	–	–
96	96 NewcelX Ltd NCEL $16.5M	1	-2	-67%	$6
97	97 DELISTED NKGen Biotech, Inc. Common Stock NKGN	1	0	0%	$138K
98	ONCS 98 DELISTED OncoSec Medical Incorporated ONCS	1	+1	–	–
99	99 DELISTED Scorpius Holdings, Inc. SCPX	1	0	0%	$1
100	100 DELISTED Adverum Biotechnologies ADVM	0	-50	-100%	$0